News

May 10, 2024 | COMPANY | NEWS | ONCOLOGY Informed Genomics scoops award for Innovation in Healthcare 10th May 2024, Birmingham – Informed Genomics, a UK-based genomic testing laboratory providing innovative cancer testing services and accredited solutions to the NHS and private sector, has been highly commended for Delivering Innovation in Health and Care. The award was presented at…

May 1, 2024 | COMPANY | NEWS | ONCOLOGY Today, 1st May, is the first day of bladder cancer awareness month. We are working with organisations across the private and public sectors to help raise awareness of this cancer, its symptoms and the novel, non-invasive test and services we offer that could transform the healthcare journey for thousands of…

April 25, 2024 | COMPANY | NEWS | ONCOLOGY Today, 25th April, marks the anniversary of the completion of the human genome project in 2003 and the discovery of the double helix in 1953. As we celebrate DNA Day, our recently appointed CEO, Simon Davis, reflects on how much progress has been made in genomics since then and how…

Written by Victoria Simms May 2023. Reviewed by Celina Whalley April 2024 APRIL 17, 2024 | COMPANY | NEWS May marks Bladder Cancer Awareness Month, four weeks dedicated to raising awareness of this disease, its symptoms, and the current realities for those impacted by bladder cancer both directly and indirectly. As we continue to implement…

April 12, 2024 | COMPANY | NEWS Bladder Cancer Awareness month is quickly approaching and Nonacus is delighted to share that The Daily Telegraph has published an article about recognising the symptoms of bladder cancer, and the importance of early diagnosis of bladder cancer featuring GALEAS Bladder. This piece features insightful interviews from key opinion…

April 2, 2024 | COMPANY | NEWS Genetic testing company, Nonacus, has launched GALEASTM Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumors, allowing clinicians to accurately diagnose cancers and tailor treatments. Comprehensive genomic profiling (CGP) is a well-established technique used to analyse the genomic profile of a tumor, allowing…

February 7, 2024 | COMPANY | NEWS | ONCOLOGY Informed Genomics is supporting NHS England with the launch of a new genetic testing programme targeting tens of thousands of people with Jewish ancestry who are more likely to carry a genetic fault that can increase the risk of developing some cancers. The NHS Jewish BRCA Testing Programme is part…

January 24, 2024 | COMPANY | NEWS Nonacus has launched its latest next generation sequencing (NGS) test in the GALEAS product range – the GALEAS HereditaryPlus panel – which provides laboratories and clinicians with a comprehensive and streamlined way to diagnose patients with cancer that is caused by inherited genetic mutations. Eliminating the need for MLPA in hereditary…

January 11, 2024 | COMPANY | NEWS | ONCOLOGY Informed Genomics Limited – a private UKAS accredited cancer genetic testing laboratory offering comprehensive sequencing services – has appointed Simon Davis, their Commercial Director, as their new Chief Executive Officer, effective immediately. Simon’s experience and proven track record of commercial success within the life science and MedTech industries over the…

November 3, 2023 | COMPANY | NEWS | ONCOLOGY Pioneering genetic test for bladder cancer made available to speed up detection and reduce uncomfortable hospital procedures Informed Genomics Limited and Bupa insurance have collaborated to make a pioneering genetic test for bladder cancer available for the first time in the UK. Currently, people who are suspected of having bladder…